In January 2024, Congressman Mike Gallagher, the Chair of the United States (US) House Committee on the Chinese Communist Party, introduced the “Biosecure Act,” which prohibits the US government (USG) from “procuring or obtaining biotechnology equipment or services produced or provided by a biotechnology company of concern,” participating in a...
Tag: health care
March 25, 2023
China’s 20th Party Congress in October 2022 and its March 2023 “Two Sessions” revealed the new top leadership of the Chinese Communist Party (CCP), confirmed China’s top government officials, shed light on the CCP’s current agenda, concerns, and dogmas, promulgated new policies, and presented the government’s work program. On the...
January 12, 2021
In my December blog, I overviewed China’s Dual Circulation System (DCS). To reiterate, foreign multinational corporations (MNCs) are concerned about the DCS’s emphasis on self-sufficiency, indigenous technology, and insulating China against the international market’s vagaries. Foreign MNCs, though, also see opportunities to satiate anticipated growth in domestic demand and the…
September 16, 2019
Despite the United States (US)-China trade war, renowned economist highlights that US firms continue to remain in China because of the attractiveness of China as well as limits associated with the alternatives. During a meeting with a Japanese business delegation, Chinese Premier Li Keqiang welcomes more Japanese foreign direct investment…
June 22, 2015
Foreign direct investment (FDI) in China in May increases by 7.8 percent year-over-year (YOY). New York Times expects Chinese leaders to take heed of foreign business opposition to proposed restrictive Chinese policy measures. Cisco touts plan to invest US $10 billion in China to fund innovation, equity investment, and research…
